Allianz Asset Management
TRIB

Allianz Asset Management’s Trinity Biotech TRIB Stock Holding History

Allianz Asset Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,163
Closed -$2.31M – 2675
2016
Q3 		$2.31M Sell
1,163
-33
-3% -$61.6K ﹤0.01% 1939
2016
Q2 		$2.03M Sell
1,196
-59
-5% -$99.8K ﹤0.01% 1912
2016
Q1 		$2.19M Sell
1,255
-34
-3% -$54.1K ﹤0.01% 1767
2015
Q4 		$2.27M Sell
1,289
-200
-13% -$354K ﹤0.01% 1662
2015
Q3 		$2.56M Buy
1,489
+15
+1% +$36.2K ﹤0.01% 1517
2015
Q2 		$3.99M Sell
1,474
-21
-1% -$54.5K ﹤0.01% 1453
2015
Q1 		$4.32M Sell
1,495
-170
-10% -$471K ﹤0.01% 1267
2014
Q4 		$4.37M Sell
1,665
-26
-2% -$67.2K ﹤0.01% 1262
2014
Q3 		$4.63M Sell
1,691
-151
-8% -$491K 0.01% 1096
2014
Q2 		$6.36M Sell
1,842
-57
-3% -$203K 0.01% 860
2014
Q1 		$6.9M Buy
1,899
+85
+5% +$334K 0.01% 861
2013
Q4 		$6.84M Buy
1,814
+97
+6% +$349K 0.01% 854
2013
Q3 		$5.6M Buy
1,717
+330
+24% +$965K 0.01% 885
2013
Q2 		$3.5M Buy
+1,387
New +$3.45M 0.01% 1014

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Allianz Asset Management's TRIB Position: Q4 2016 in Review

Allianz Asset Management sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 1,163 shares — an estimated $2.31M sold.

Allianz Asset Management first reported a position in TRIB in Q2 2013 and held it in 14 quarters. The position peaked at $6.9M in Q1 2014. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.

  • Allianz Asset Management reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
  • Allianz Asset Management sold 1,163 Trinity Biotech shares in Q4 2016, an estimated $2.31M.
  • Allianz Asset Management first reported a position in Trinity Biotech in Q2 2013 and held it in 14 quarters.
  • Allianz Asset Management's Trinity Biotech position peaked at $6.9M in Q1 2014.
  • 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.

Based on Allianz Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.